POPET
Physician on call Patient Engagement Trial
Pioneer Digital Health Tool to Show Clinically Significant Patient Outcomes
In a prospective, multicenter, randomized, controlled, double-blind clinical trial, POPET demonstrated statistically significant improvements for patients with allergic rhinitis and asthma.
49%
Achieved Well-Controlled Asthma (ACT>19)
27%
Control Group
Clinical Evidence
- Statistically significant improvements in activity and productivity (p<0.05)
- Enhanced emotional wellbeing and quality of life scores
- 92% study completion vs 54% in control group
- Fewer unplanned hospital visits and emergency admissions
Read the Published Study
Download Clinical Trial PDFPublished in International Forum of Allergy & Rhinology, 2015
Recognition
GE Healthymagination Award
StartUp Health
Rock Health